Cardiovascular and heart failure safety profile of vildagliptin: a meta‐analysis of 17 000 patients

E-ISSN： 1463-1326|17|11|1085-1092

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.17, Iss.11, 2015-11, pp. : 1085-1092

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta‐analysis

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1182-1191

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular safety of empagliflozin in patients with type 2 diabetes: a meta‐analysis of data from randomized placebo‐controlled trials

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. 10, 2016-10 ,pp. : 1034-1040

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical effectiveness and safety of vildagliptin in >19 000 patients with type 2 diabetes: the GUARD study

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 603-607

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis

By Bell David S. H. Lukas Mary Ann Holdbrook Frederick K. Fowler Michael B.

Current Medical Research and Opinion, Vol. 22, Iss. 2, 2006-02 ,pp. : 287-296

Informa Healthcare

Access to resources Recommend Favorite

The Effect of Exercise Training Intensity on Quality of Life in Heart Failure Patients: A Systematic Review and Meta-Analysis

Cardiology, Vol. 136, Iss. 2, 2016-08 ,pp. : 79-89

Karger

Access to resources Recommend Favorite